Ignite Creation Date:
2024-05-05 @ 10:23 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004747
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2000-02-24
Brief Title:
Phase II Randomized Double-Blind Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis
Sponsor:
National Center for Research Resources NCRR
Organization:
Office of Rare Diseases ORD
Organization Data
Organization:
Office of Rare Diseases ORD
Class:
NIH
Study ID:
19911663
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Center for Research Resources NCRR
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Vanderbilt University Medical Center | OTHER |